The 38th Annual Congress of the European Association of Nuclear Medicine (EANM), took place from October 4 to 8 in Barcelona, Spain. Recognised globally as the leading event in nuclear medicine, the congress coincided with the association’s 40th anniversary and brought together more than 9.000 professionals, including clinicians, researchers, academics and industry experts. 

With a record number of participants, the scientific programme featured over 200 sessions covering the latest advances in nuclear medicine, with a focus on theranostics (combining diagnosis and therapy), cutting-edge imaging techniques, neuroimaging and nuclear cardiology.

We were pleased to join an exciting live symposium during the conference, hosted by PVI, PeerView Institute for Medical Education, focused on advancing early diagnosis with PET imaging and biomarkers. During this symposium, Lyduine E. Collij shared insights from the AMYPAD project and spoke alongside Prof. Dr. Alexander Drzezga and Prof. dr. Silvia Morbelli.

For more information about the conference, please visit: https://eanm25.eanm.org/

Next year, EANM will convene in Vienna for its 39th Annual Congress from 17-21 October 2026. Save the date!